-
The Burden of Epilepsy in Thailand: Estimating Societal Costs and Quality of Life
-
Tau burden across Braak stages is associated with regionally specific amyloid accumulation
-
Caregiver Mental Health and Sociodemographic Factors Associated with the Burden of Care in Taiwan Among Primary Caregivers of Patients with Major Depressive Disorder: A Cross-Sectional Study
-
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
-
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
-
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
-
Taking care of psychotic disorders globally, beyond clinical management
-
Strengthening the global mental health workforce through collaborative education
-
An excitement building in the development of psychological treatments for schizophrenia
-
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
-
The new German evidence‐ and consensus‐based schizophrenia guideline
-
The ‘Coming of Global Christianity’ A Challenge to Northern Mental Health? (Jenkins, P. The Next Christendom: The Coming of Global Christianity (2007) The Next Christendom: The Coming of Global Christianity (Revised and Expanded Edition. Oxford: Oxford UP, XVIII + 316 pp., 23.6x15.7 cm, ISBN 0195168917, $14.95.)
-
ILAE‐YES global webinar series: Integrating clinical and basic science in epilepsy research
-
Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder
-
Health response to problematic usage of the internet: A global survey on trends, available treatments and key challenges
-
Correction to: GNW theoretical framework and the “adversarial testing of global neuronal workspace and integrated information theories of consciousness”
-
The Global Epilepsy Needs Study (GENS): A mixed‐methods, multi‐country exploration of the unmet psychosocial and everyday needs of people with epilepsy
-
What does it take to make real‐world changes in schizophrenia care?
-
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
-
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
-
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program
-
Empowering Patients, Preventing Strokes: Knowledge of Risk Factors and Associated Factors, Prevention Strategies, and Treatment Awareness Among Chronic Disease Patients in Southern Ethiopia
-
Transcranial direct current stimulation plus concurrent activity may influence task prioritization during walking in people with Parkinson’s disease – initial findings
-
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study